Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05779397 · ClinicalTrials.gov registry record · NA
Clinical Performance of Masimo Rad-GT
A NA study of Healthy, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT05779397 is a NA study of Healthy that has completed, run by Masimo Corporation. The registered enrollment target is 68 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05779397, a NA study of Healthy, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is designed to validate the clinical performance of Masimo Rad-GT in the accuracy of temperature measurements.
Conditions Studied
Interventions
- DEVICE Masimo RAD-GT
Study Locations (1)
California
- Masimo Corporation - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2023-02-20 |
| Est. Completion | 2023-02-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05779397
The ClinicalTrials.gov registry entry for NCT05779397 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Masimo RAD-GT is the first listed.
NCT05779397 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05779397 about?
NCT05779397 is a clinical study titled "Clinical Performance of Masimo Rad-GT". The study is designed to validate the clinical performance of Masimo Rad-GT in the accuracy of temperature measurements.
What is the current status of trial NCT05779397?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2023-02-20. Estimated completion is 2023-02-23.
What conditions does trial NCT05779397 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT05779397?
The interventions under investigation include: Masimo RAD-GT (DEVICE).
Who is sponsoring clinical trial NCT05779397?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05779397 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.